Medical genetics company Invitae (NYSE: NYSE:NVTA) announced on Tuesday the appointment of Ana Schrank as its new Chief Financial Officer, effective from October 2, 2023. Schrank will take over from the interim CFO Robert Dickey, who has been serving in the role since August 2023. Dickey will transition to a consulting role within the company and work closely with Schrank and the leadership team to ensure a seamless transition.
Schrank comes with over 25 years of experience in finance. She held the position of CFO at Truepill, Inc., a digital health platform, where she led finance, accounting, and human resources functions. From 2020 to 2022, she served as CFO at Collective Health, overseeing finance functions, strategy, customer analytics, and actuarial efforts. Earlier in her career, she spent over two decades at McKesson Corporation (NYSE:MCK) in various leadership roles.
Ken Knight, President and CEO of Invitae expressed enthusiasm about Schrank's appointment. He highlighted her track record of driving growth, transforming businesses and building high-performing teams as a great fit for Invitae's current needs and future plans.
Schrank also expressed excitement about joining Invitae. She stated that she looks forward to using her passion for patients and broad financial background to focus on identifying durable paths for profitable growth in support of Invitae’s mission.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.